Cargando…
The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2
Long noncoding RNAs (lncRNAs) are emerging as important regulators during tumorigenesis by serving as competing endogenous RNAs (ceRNAs). In this study, the qRT-PCR results indicated that the lncRNA protein disulfide isomerase family A member 3 pseudogene 1 (PDIA3P) was overexpressed in oral squamou...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626923/ https://www.ncbi.nlm.nih.gov/pubmed/29246288 http://dx.doi.org/10.1016/j.omtn.2017.08.015 |
_version_ | 1783268625315004416 |
---|---|
author | Sun, Cheng-Cao Zhang, Ling Li, Guang Li, Shu-Jun Chen, Zhen-Long Fu, Yun-Feng Gong, Feng-Yun Bai, Tao Zhang, Ding-Yu Wu, Qing-Ming Li, De-Jia |
author_facet | Sun, Cheng-Cao Zhang, Ling Li, Guang Li, Shu-Jun Chen, Zhen-Long Fu, Yun-Feng Gong, Feng-Yun Bai, Tao Zhang, Ding-Yu Wu, Qing-Ming Li, De-Jia |
author_sort | Sun, Cheng-Cao |
collection | PubMed |
description | Long noncoding RNAs (lncRNAs) are emerging as important regulators during tumorigenesis by serving as competing endogenous RNAs (ceRNAs). In this study, the qRT-PCR results indicated that the lncRNA protein disulfide isomerase family A member 3 pseudogene 1 (PDIA3P) was overexpressed in oral squamous cell carcinoma (OSCC) and decreased the survival rate of OSCC patients. CCK-8 and clonal colony formation assays were used to detect the effects of PDIA3P on proliferation. Results revealed that silencing PDIA3P by small interfering RNA (siRNA) inhibited OSCC cell proliferation and repressed tumor growth and reduced the expression of proliferation antigen Ki-67 in vivo. Furthermore, the interaction between PDIA3P and miRNAs was then analyzed by qRT-PCR and luciferase reporter gene assay. We found that PDIA3P negatively regulated miR-185-5p in OSCC cells. Simultaneously, we found that silencing PDIA3P by siRNA suppressed proliferation via miR-185-5p in OSCC cells. Moreover, silencing PDIA3P by siRNA inhibited CCND2 protein (no influence on mRNA levels) expression via miR-185-5p in OSCC cells, and CCND2 facilitated cell proliferation of SCC4 and SCC15 cells induced by sh-PDIA3P#1. Therefore, our study demonstrated that PDIA3P may be a therapeutic target for the treatment of OSCC. |
format | Online Article Text |
id | pubmed-5626923 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | American Society of Gene & Cell Therapy |
record_format | MEDLINE/PubMed |
spelling | pubmed-56269232017-10-10 The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2 Sun, Cheng-Cao Zhang, Ling Li, Guang Li, Shu-Jun Chen, Zhen-Long Fu, Yun-Feng Gong, Feng-Yun Bai, Tao Zhang, Ding-Yu Wu, Qing-Ming Li, De-Jia Mol Ther Nucleic Acids Original Article Long noncoding RNAs (lncRNAs) are emerging as important regulators during tumorigenesis by serving as competing endogenous RNAs (ceRNAs). In this study, the qRT-PCR results indicated that the lncRNA protein disulfide isomerase family A member 3 pseudogene 1 (PDIA3P) was overexpressed in oral squamous cell carcinoma (OSCC) and decreased the survival rate of OSCC patients. CCK-8 and clonal colony formation assays were used to detect the effects of PDIA3P on proliferation. Results revealed that silencing PDIA3P by small interfering RNA (siRNA) inhibited OSCC cell proliferation and repressed tumor growth and reduced the expression of proliferation antigen Ki-67 in vivo. Furthermore, the interaction between PDIA3P and miRNAs was then analyzed by qRT-PCR and luciferase reporter gene assay. We found that PDIA3P negatively regulated miR-185-5p in OSCC cells. Simultaneously, we found that silencing PDIA3P by siRNA suppressed proliferation via miR-185-5p in OSCC cells. Moreover, silencing PDIA3P by siRNA inhibited CCND2 protein (no influence on mRNA levels) expression via miR-185-5p in OSCC cells, and CCND2 facilitated cell proliferation of SCC4 and SCC15 cells induced by sh-PDIA3P#1. Therefore, our study demonstrated that PDIA3P may be a therapeutic target for the treatment of OSCC. American Society of Gene & Cell Therapy 2017-09-21 /pmc/articles/PMC5626923/ /pubmed/29246288 http://dx.doi.org/10.1016/j.omtn.2017.08.015 Text en © 2017 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Sun, Cheng-Cao Zhang, Ling Li, Guang Li, Shu-Jun Chen, Zhen-Long Fu, Yun-Feng Gong, Feng-Yun Bai, Tao Zhang, Ding-Yu Wu, Qing-Ming Li, De-Jia The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2 |
title | The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2 |
title_full | The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2 |
title_fullStr | The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2 |
title_full_unstemmed | The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2 |
title_short | The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2 |
title_sort | lncrna pdia3p interacts with mir-185-5p to modulate oral squamous cell carcinoma progression by targeting cyclin d2 |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626923/ https://www.ncbi.nlm.nih.gov/pubmed/29246288 http://dx.doi.org/10.1016/j.omtn.2017.08.015 |
work_keys_str_mv | AT sunchengcao thelncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2 AT zhangling thelncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2 AT liguang thelncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2 AT lishujun thelncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2 AT chenzhenlong thelncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2 AT fuyunfeng thelncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2 AT gongfengyun thelncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2 AT baitao thelncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2 AT zhangdingyu thelncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2 AT wuqingming thelncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2 AT lidejia thelncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2 AT sunchengcao lncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2 AT zhangling lncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2 AT liguang lncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2 AT lishujun lncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2 AT chenzhenlong lncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2 AT fuyunfeng lncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2 AT gongfengyun lncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2 AT baitao lncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2 AT zhangdingyu lncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2 AT wuqingming lncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2 AT lidejia lncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2 |